132 Chapter 7 16. Schurink NW, van Kranen SR, Berbee M et al (2021) Studying local tumour heterogeneity on MRI and FDG-PET/CT to predict response to neoadjuvant chemoradiotherapy in rectal cancer. Eur Radiol 31(9):7031-7038. https://doi.org/10.1007/s00330-021-07724-0 17. van Griethuysen JJM, Lambregts DMJ, Trebeschi S et al (2020) Radiomics performs comparable to morphologic assessment by expert radiologists for prediction of response to neoadjuvant chemoradiotherapy on baseline staging MRI in rectal cancer. Abdom Radiol (NY) 45(3):632643. https://doi.org/10.1007/s00261-019-02321-8 18. Beets-Tan RGH, Lambregts DMJ, Maas M et al (2018) Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting [published correction appears in Eur Radiol. 2018 Jan 10;:]. Eur Radiol 28(4):1465-1475. https://doi.org/10.1007/ s00330-017-5026-2 19. Ziegler E, Urban T, Brown D et al (2020) Open Health Imaging Foundation Viewer: An Extensible Open-Source Framework for Building Web-Based Imaging Applications to Support Cancer Research. JCO Clin Cancer Inform 4:336-345. https://doi.org/10.1200/CCI.19.00131 20. Mandard AM, Dalibard F, Mandard JC et al (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73(11):2680-2686. https://doi.org/10.1002/1097-0142(19940601)73:11<2680::aidcncr2820731105>3.0.co;2-c 21. Haak HE, Maas M, Lahaye MJ et al (2020) Selection of Patients for Organ Preservation After Chemoradiotherapy: MRI Identifies Poor Responders Who Can Go Straight to Surgery. Ann Surg Oncol 27(8):2732-2739. https://doi.org/10.1245/s10434-020-08334-8 22. Seo N, Kim H, Cho MS, Lim JS (2019) Response Assessment with MRI after Chemoradiotherapy in Rectal Cancer: Current Evidences. Korean J Radiol 20(7):1003-1018. https://doi.org/10.3348/ kjr.2018.0611 23. van der Sande ME, Beets GL, Hupkens BJ et al (2019) Response assessment after (chemo) radiotherapy for rectal cancer: Why are we missing complete responses with MRI and endoscopy?. Eur J Surg Oncol 45(6):1011-1017. https://doi.org/10.1016/j.ejso.2018.11.019 24. Maas M, Lambregts DM, Nelemans PJ, et al. (2015) Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment. Ann Surg Oncol 22(12):3873-3880. https://doi. org/10.1245/s10434-015-4687-9 25. Dijkhoff RAP, Beets-Tan RGH, Lambregts DMJ, Beets GL, Maas M (2017) Value of DCE-MRI for staging and response evaluation in rectal cancer: A systematic review. Eur J Radiol 95:155-168. https://doi.org/10.1016/j.ejrad.2017.08.009 26. O’Connor JP, Rose CJ, Waterton JC, Carano RA, Parker GJ, Jackson A (2015) Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome. Clin Cancer Res 21(2):249-257. https://doi.org/10.1158/1078-0432.CCR-14-0990. 27. Miranda J, Tan GXV, Fernandes MC et al (2022) Rectal MRI radiomics for predicting pathological complete response: Where we are. Clin Imaging 82:141-149. https://doi.org/10.1016/j. clinimag.2021.10.005 28. Meng Y, Zhang Y, Dong D et al (2018) Novel radiomic signature as a prognostic biomarker for locally advanced rectal cancer. J Magn Reson Imaging 10.1002/jmri.25968. https://doi. org/10.1002/jmri.25968 29. Petkovska I, Tixier F, Ortiz EJ et al (2020) Clinical utility of radiomics at baseline rectal MRI to predict complete response of rectal cancer after chemoradiation therapy. Abdom Radiol (NY) 45(11):3608-3617. https://doi.org/10.1007/s00261-020-02502-w 30. Cui Y, Yang X, Shi Z et al (2019) Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 29(3):1211-1220. https://doi.org/10.1007/s00330-018-5683-9
RkJQdWJsaXNoZXIy MjY0ODMw